Blog | HemaCare

HemaCare Rings in the New Year with New Headquarters and a Cutting-Edge Collection Center

Feb 5, 2019 10:08:00 AM / by Nancy Andon, MSc posted in GMP, Apheresis, Cell Therapy, cGMP, clinical grade compliance, clinical trial


HemaCare Corporation’s new global headquarters is officially open for business! The company started 2019 in a brand new 40,000 square foot space in a newly modernized 44-acre corporate campus located in the heart of the San Fernando Valley at Northridge. The design and construction of the cutting-edge facility provide a spacious workspace that promotes the well-being of its occupants, while significantly expanding the company’s on-site capabilities.

Read More

Tregs opens up Exciting Opportunities for Cell Based Therapies

Sep 22, 2014 1:00:40 PM / by Shweta posted in GMP, GVHD, leukapheresis, Cell Therapy, cGMP, clinical grade compliance, Innovation, research, T lymphocytes, white blood cells, Whole Blood


Manufacturing of clinical grade Tregs for cell based therapies

Read More

BIO2014 Highlight: GMP Compliance by Cell Therapy Companies

Jun 30, 2014 6:06:44 PM / by Maria posted in Cell Therapy, cGMP, Regenerative Medicine, Stem Cells


cGMP compliance is a critical requirement by companies offering cell therapy. Here, we summarize the details from a panel discussion at BIO 2014.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts